Evidence map›Paper›PMID 23008448›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Katja Aviszus, Megan K L Macleod, Greg A Kirchenbaum, Thiago O Detanico, Ryan A Heiser, James B St Clair, Wenzhong Guo, Lawrence J Wysocki

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Regulatory B cells require antigen recognition for effective allograft tolerance induction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katja AviszusIntegrated Department of Immunology, National Jewish Health and University of Colorado School of Medicine, Denver, CO 80206, USA.
Megan K L Macleod
Greg A Kirchenbaum
Thiago O Detanico
Ryan A Heiser
James B St Clair
Wenzhong Guo
Lawrence J Wysocki

Funding

Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C · 1985 to 2011
$11.7M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
IMMUNE RECOGNITION AND TOLERANCE OF ANTIBODY DIVERSITYR01AI033613 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 1993 to 2009
$2.7M
Functional Anergy in B CellsR01AI073945 · NIAID · NATIONAL JEWISH HEALTH · PI WYSOCKI, LAWRENCE J · 2008 to 2012
$1.9M
Autoantibody and BCR peptide-specific T cells in lupus nephritisF30DK091102 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI ST CLAIR, JAMES BEN · 2011 to 2014
$142k
NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI033613NIAID NIH HHS R01 AI073945NIAID NIH HHS T32 AI007405NIDDK NIH HHS F30 DK091102NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Autoreactive anergic B lymphocytes are considered to be dangerous because of their potential for activation and recruitment into autoimmune responses. However, they persist for days and constitute ∼5% of the B cell pool. We assessed their functional potential in the Ars/A1 transgene model, where anergic B cells express a dual-reactive Ag receptor that binds, in addition to a self-Ag, the hapten p-azophenylarsonate (Ars). When Ars/A1 B cells were transferred into adoptive recipients that were immunized with foreign proteins covalently conjugated with Ars, endogenous IgG immune responses to both were selectively and severely diminished, and the development of T helper cells was impaired. Approximately 95% inhibition of the anti-Ars response was attained with ∼4000 transferred Ars/A1 B cells through redundant mechanisms, one of which depended on their expression of MHC class II but not upon secretion of IL-10 or IgM. This Ag-specific suppressive activity implicates the autoreactive anergic B cell as an enforcer of immunological tolerance to self-Ags.

Indexed as

Antibody FormationAdoptive TransferAnimalsAutoantigensB-Lymphocyte SubsetsCells, CulturedClonal AnergyEpitopes, B-LymphocyteImmunoglobulin GImmunosuppression TherapyMiceMice, 129 StrainMice, Inbred AMice, Inbred C57BLMice, KnockoutMice, TransgenicAutoantigensEpitopes, B-LymphocyteImmunoglobulin Gp-Azobenzenearsonate

Identifiers

PMID23008448
PMCPMC3478495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.